Identification of novel mutations in Mexican patients with Aarskog–Scott syndrome

Mariana Pérez‐Coria, José de Jesús Lugo-Trampe, Michell Zamudio‐Osuna, Iram P. Rodríguez‐Sánchez, Ángel Lugo‐Trampe, Beatriz de la Fuente‐Cortez, Luis Daniel Campos-Acevedo, L. Villarreal

Molecular Genetics & Genomic Medicine · 2015 · 15 citations · 20 references

DOIFull text

Open access

Concepts

Abstract

Aarskog-Scott syndrome (AAS), also known as faciogenital dysplasia (FGD, OMIM # 305400), is an X-linked disorder of recessive inheritance, characterized by short stature and facial, skeletal, and urogenital abnormalities. AAS is caused by mutations in the FGD1 gene (Xp11.22), with over 56 different mutations identified to date. We present the clinical and molecular analysis of four unrelated families of Mexican origin with an AAS phenotype, in whom FGD1 sequencing was performed. This analysis identified two stop mutations not previously reported in the literature: p.Gln664* and p.Glu380*. Phenotypically, every male patient met the clinical criteria of the syndrome, whereas discrepancies were found between phenotypes in female patients. Our results identify two novel mutations in FGD1, broadening the spectrum of reported mutations; and provide further delineation of the phenotypic variability previously described in AAS.

References

20